Central obesity is the subfraction which carries most of the risks for comorbidities. In this overview we suggest that this is due to neuroendocrine perturbations, where the hypothalamic ± pituitary ± adrenal (HPA) axis assumes a central role. The HPA axis is stimulated by central factors, which are often called stress. This is followed by discrete, periodical elevations of cortisol secretion during every day conditions. Such observations require diurnal measurements under undisturbed conditions. Saliva cortisol is useful for such purposes. It seems likely, based on cross-sectional observations in men and longitudinal studies in animals that a prolonged period of HPA axis stimulation is followed by a continuous degradation of the regulatory mechanisms. An end stage is a rigid cortisol secretion with low morning values. In parallel with this is a diminished function of the feed-back control as well as an inhibition of growth and sex steroid hormones. Evidence also suggests that the sympathetic nervous centers become activated in parallel. The net effects of this cascade of neuroendocrine ± endocrine pertubations will be insulin resistance as well as visceral accumulation of body fat. These are effects of cortisol in combination with the diminished secretion of growth and sex steroid secretions, which in normal concentrations antagonize the cortisol effects. Blood pressure will also be elevated, which might be a consequence of central stimulation of the sympathetic nervous system, with added effects of insulin. What has developed is a hypothalamic arousal with the Metabolic Syndrome as a consequence. The feed-back regulation of the HPA axis has a key position in this chain of events. This control is mediated via glucocorticoid receptors in the lower parts of the brain. The gene for this receptor has shown polymorphisms which are associated with poorly regulated cortisol secretion, centeral obesity, insulin resistance and hypertension.
Introduction
Obesity can be subdivided into a group of centrally localized excess body fat, where much fat is stored in intra-abdominal, visceral depots, and a peripheral gluteofemoral subgroup. The former carries the majority of the risk of obesity developing complicating diseases (cardiovascular disease, diabetes type 2 and stroke) and is closely statistically associated with the risk factors for these diseases, including insulin resistance, dyslipidaemia, hypertension and thrombogenetic factors. 1 The major question then is why central, visceral obesity is associated with serious complications, unlike peripheral obesity, which is affected to a much lesser degree. We were struck early on by the similarities between visceral obesity and Cushing's syndrome. Both have large intra-abdominal depots, insulin resistance, dyslipidaemia, hypertension and risk of developing diabetes and cardio-cerebrovascular disease. We therefore started to examine the regulation of cortisol secretion in visceral obesity.
The hypothalamic ± pituitary ± adrenal axis in obesity
Cortisol secretion is regulated by the hypothalamic ± pituitary ± adrenal (HPA) axis, mainly by stimuli centred in hypothalamic nuclei. These centres receive inputs from the central nervous system in the form of signals from, for example, the senses and feeding. The regulating mechanisms are arranged so as to counteract threats to homeostasis (`stress'), and balancing mechanisms ®lter the resulting signals (coping). The HPA axis activity is controlled by a feedback inhibitory loop, exerted by glucocorticoid receptors (GR), located mainly in the hippocampus region of the brain. The GRs provide feedback inhibitory signals when occupied by cortisol, and thereby prevent excess cortisol secretion.
Cortisol secretion has been much studied in obesity. In brief, the production seems to be elevated, but circulating levels tend to be normal or low, probably because of an elevated peripheral uptake and frac-tional turnover rate. 2 These are studies in obesity in general, not subdivided into central and peripheral distribution subgroups.
When studying subgroups it seems clear that there are differences. In relation to the waistahip circumference ratio (WHR) urinary cortisol excretion appeared to be elevated, and ACTH stimulation of cortisol secretion and the response to laboratory stress increased. 3 Furthermore, the response of both ACTH and cortisol to corticotropin-releasing hormone (CRH) and arginine vasopressin was elevated in women with a high WHR in comparison with women with a low ratio. 4, 5 These results indicated differences in the regulatory pathways of the HPA axis between central and peripheral obesity. The nature of this difference was, however, not clear because most of these tests were performed with maximal doses of the challenging hormone. Furthermore, the elevated cortisol secretion 3 was not a particularly robust ®nding, and the exaggerated CRH response was not found in men (Pasquali, personal communication, and own unpublished results).
Methodological developments
In order to clarify these points and to attempt to de®ne putative abnormal regulatory elements in the HPA axis further, we decided to re-examine this important question with the following prerequisites.
The long-term effects of HPA axis activity on the periphery are exerted by the everyday activity of this axis. This means that measurements have to be performed during everyday conditions. This excludes blood sampling, which by itself is disturbing, particularly when performed in the unfamiliar milieu of a laboratory or hospital. Urine collection for measurements of cortisol excretion gives information on the total cortisol secretion during the period of sampling, but not on the kinetics of HPA axis activity during that period. Furthermore, urine collection during work is impractical.
For these reasons we decided to measure cortisol in saliva, which contains free cortisol at the same concentration as in circulation, and is independent on saliva¯ow. 6, 7 Saliva is easily sampled repeatedly except during sleep. In order to cover the activity over the day, several samples (n 7) were collected, covering the high morning and the low evening secretion. A standardized lunch was provided to examine the response to feeding. Furthermore, the probands reported perceived stress in relation to saliva sampling, and stress-related cortisol values were obtained. Finally, a low dose (0.5 mg) dexamethasone suppression test was performed. The conventional, higher dose of 1 mg is not sensitive enough for the purposes in question. 3, 8 With this set of measurements we believe it is possible to map the basal activity of the HPA axis, direct stimulation of hypothalamic centra by the physiological stimulus of feeding, the in¯uence of perceived stress, as well as the ef®ciency of the feedback inhibitory loop. This could be performed under ordinary everyday activities, as seen in preliminary feasibility testing. 9, 10 
Materials and methods
These tests were applied on a population scale, including randomly selected cohorts of middle-aged men (age 51 y; n 1302) and women (age 40 y; n 1464). From primary groups, examined with questionnaires and self-measurements of anthropometry (participation rate about 80%), a further randomization was performed for more detailed examinations. So far this study has been ®nalized in the men (n 287). Examinations included, in addition to salivary cortisol as described above, measurements of body mass index (BMI, weight, kgaheight 2 , m 2 ), the WHR, sagittal and abdominal diameter (D) and an approximation of visceral fat mass 11 in an anthropometric group of measurements. Hormones were also determined (testosterone and insulin-like growth factor I, IGF-I, a measurement of growth hormone secretion), as well as metabolic factors (fasting glucose, insulin, triglycerides) and total, LDL and HDL cholesterol. Furthermore, haemodynamic measurements were performed (systolic and diastolic blood pressure and heart rate).
Results
A large variation was, as expected, obtained in the saliva cortisol measurements. By a weighting procedure it was possible, however, to analyse the in¯uence of a high or low variability of the day-curve of cortisol on the other variables. The following ®ndings were made. A high variability is the characteristic of a normal HPA function with high morning and low evening values, a brisk response to feeding, and a sensitive dexamethasone suppression. In contrast, a low variability is a day-curve with low morning values and a rigid cortisol secretion over the day with a small feeding response and poor dexamethasone inhibition. This is a highly pathological reaction pattern of the HPA axis, seen as a result of a chronic reaction to stress. 12 Both these curve types of cortisol secretion were associated with quite different results of other measurements. With the normal curve, lower than average values were obtained for BMI and WHR, total and LDL cholesterol and blood pressure, while IGF-I was higher than average. We concluded from these results that a normal function of the HPA axis is associated with perfect health in anthropometric factors, endocrine systems, metabolism, including cholesterol, and haemodynamic measurements. 9, 10 In sharp contrast were similar measurements in the men with an abnormal HPA axis as described above. Such men have a number of abnormal values, particularly when stress-related cortisol is considered. Here BMI, WHR and D are elevated, testosterone and IGF-I low, insulin, glucose, triglycerides, total and LDL cholesterol are high, while HDL is low, and both blood pressure and heart rate are elevated. These men have abdominal obesity, perturbations of endocrine secretions, the Metabolic Syndrome, including abnormal cholesterol metabolism and hypertension. 9, 10 These results clearly point out the strong associations between the status of HPA axis regulation and health or disease in several somatic systems. A healthy HPA axis is associated with excellent general health and vice versa. Since the HPA axis is largely dependent on signals from the central nervous system, this might be considered to be signs of mens sana in corpore sano.
The HPA axis activity is of vital importance for the regulation of a number of somatic systems via the multitude of cortisol effects. Furthermore, through interactions with other central endocrine axes, the effects of these hormones are also dependent on the HPA axis status. When the HPA axis is overactive, sex steroid, growth hormone and thyroid secretions are inhibited, as seen in the results referred to above. This is a well-established phenomenon. 13 The ensuing endocrine perturbations would be expected to be followed by widespread, peripheral consequences in both metabolic and anthropometric and, perhaps, haemodynamic systems. The consequences for visceral fat mass, insulin resistance and other metabolic aberrations have been described previously. 1, 14, 15 It should be noted that the resulting endocrine abnormalities of HPA axis perturbations are most likely followed by visceral fat accumulation. 14 This is clearly seen in Cushing's syndrome, and disappears with treatment. In the new studies referred to here, 9, 10 BMI, WHR and D are all strongly (P`0.001) associated statistically with the tests of stimulated HPA axis activity in particular. Mechanisms for these connections between HPA axis activity and its endocrine perturbations and visceral fat accumulation have been described. 14 It therefore seems possible to suggest that the widespread associations between measurements of central obesity and a number of diseases and their risk factors are due to the perturbations of the HPA axis, which is responsible for endocrine and metabolic regulations of major importance.
Blood pressure
The relationships to the haemodynamic factors require a comment. Many researchers believe that insulin resistance and its hyperinsulinaemia are responsible for blood pressure elevation. 16, 17 We also found a statistical relationship between insulin resistance and blood pressure in the studies referred to. 18 However, the statistical association is much stronger between measurements of HPA axis activity and blood pressure as well as heart rate, in fact this association remains signi®cant in multivariate analyses, where the in¯uence of insulin and insulin resistance disappear. These ®nd-ings suggest that the blood pressure and heart rate elevations are due to central mechanisms, activated in parallel with the HPA axis. The sympathetic nervous system and the HPA axis have adjacent stimulatory centres in the hypothalamic area, which are closely functionally coupled and are often activated in parallel. 13 This would then indicate a hypothalamic arousal, in agreement with the consensus that early essential hypertension originates from such a mechanism. 19 A parallel activation of the HPA axis would be responsible for the metabolic perturbations observed, including insulin resistance and hyperinsulinaemia.
Stageing
The two reaction patterns of the HPA axis, mentioned above, are extremes. Between the normal and severely perturbed HPA axis regulatory status are a number of intermediate reaction patterns. These include a normal, basic HPA axis activity, with a high variability, stimulated by perceived stress. Stress-related cortisol secretion on the basis of a normal axis is also followed by anthropometric and metabolic perturbations, but not by endocrine or haemodynamic abnormalities.
In a next stage there must be a transition between the normal basic reactivity of the HPA axis down to the rigid, nonreactive ®nal stage, described in a previous section. We postulate that this is occurring gradually and includes additional abnormalities in the secretion of other hormones and haemodynamic variables. Diminished dexamethasone suppressibility is also occurring.
We see all these stages in the measurements.
9,10
The studies are so far only cross-sectional, but we hypothesize that there is a temporal development from one stage to another, with stress-bombardment of various frequencies and intensity as the responsible factors. This interpretation is also suggested by the measurements of stress-related cortisol secretion, and the results of stress-sensitivity in other studies. 3, 20 Observations in chronically stressed animals show such a development, 12 lending support to our tentative conclusion. Prospective studies will elucidate this important problem.
Endocrine subgrouping
The stageing analyses discussed in the previous section suggest that the endocrine abnormalities in¯u-ence, with different power of input, the peripheral consequences of the endocrine perturbations. Early in the putative developmental phases, elevated cortisol is clearly of importance. Later on, when cortisol secretion becomes low, the diminished effects of sex Neuroendocrine abnormalities in visceral obesity P Bjo Èrntorp and R Rosmond steroid and growth hormones are probably responsible for the peripheral effects on both insulin sensitivity and visceral fat mass. We have previously shown that this is possible by studying the mechanisms involved, as well as performing studies where sex steroid or growth hormones have been administered in a physiological way. Such substitution is followed by considerable improvement of both insulin sensitivity and visceral fat mass in subjects with an apparently normally functioning HPA axis. 21, 22 One may then wonder whether or not isolated de®ciencies of sex steroid andaor growth hormones will be associated with peripheral disturbances in the systems measured in the men studied. This seems to be the case. By utilizing arbitrary limits for de®ciency of testosterone or IGF-I, groups are appearing with widespread abnormalities in obesity, metabolic and haemodynamic measurements. This is occurring with, but also without evidence for HPA axis involvement. 23 This is in accordance with case-control studies of men with isolated growth hormone or testosterone de®ciencies, which show such abnormalities, which are nearly or totally normalized upon optimal hormonal substitutions. 21, 22 In addition, both testosterone and growth hormone de®ciencies are risk factors for the development of diabetes cardiovascular disease and premature mortality. 24 ± 26 The existence of subgroups with primary de®ciency of testosterone andaor growth hormone is also indicated by statistical path-analyses. 23 In the total material of men, HPA axis abnormalities are followed by low testosterone and IGF-I values, in turn followed by high WHR or D, and then come the metabolic perturbations. This indicates that the putative chain of events could start at any of the points of HPA axis abnormalities, low testosterone or IGF-I, or even directly with abdominal localization of body fat.
Associations between the HPA axis and obesity Interestingly, when BMI is introduced in this model there is a direct connection between HPA axis abnormalities and BMI. 23 This suggests that cortisol secretion is directly associated with obesity. Leptin was directly and closely correlated with the BMI, suggesting leptin resistance. Recent studies indicate that cortisol may indeed induce leptin resistance by interference with the signalling system of the leptin receptor. 27 This suggests the possibility that the HPA axis perturbations disclosed may also induce obesity by interference with the regulatory function of the leptin system.
The feedback inhibitory system
The activity of the HPA axis is controlled by a feedback inhibitory system, which prevents excessive cortisol secretion and its damaging effects. This control is exerted by GRs mainly in the hippocampus area of the brain. We have observed abnormalities in the function of these GRs in several studies. First, men with elevated WHR have a decreased sensitivity to the inhibitory power of cortisol secretion by dexamethasone. 8 Furthermore, the same men show a parallel decreased sensitivity of the peripheral GR function in a fully controlled adipose tissue culture system (Ottosson et al, unpublished). The latter results allow an analysis of the character of this de®cient function. Both a decreased sensitivity and responsiveness seem to be at hand. The former might be due to a faulty regulation of GR density and the latter might indicate that an abnormal protein is produced. With this background, as well as the information that HPA axis regulation is strongly dependent on genetic factors, 28 we decided to examine the GR gene.
Sequencing of critical parts of the coding domains of the gene showed no abnormalities. This included exons 9a and b, the steroid binding domain, and exon 2, included in the DNA-binding domain (unpublished observations). This might have been the expected result because major polymorphisms in the coding parts of the gene would cause much more severe dysfunctions than those we have uncovered.
Further studies utilizing restriction fragment length polymorphism techniques have, however, revealed abnormalities. These studies have been performed in collaboration with the Bouchard group in Canada. The restriction enzyme Bcl I produces two fragments of different length (4.5 and 2.3 kb, respectively), where the longer fragment is associated with abdominal obesity, insulin resistance and hypertension. 29 ± 31 Furthermore, and more interestingly, the presence of this 4.5 kb allele is also directly and strongly associated with GR function, 31 particularly in homozygotes, while heterozygotes (4.5a2.3 kb allele) show signi®cant, but less powerful associations. The frequency of homozygotes is as large as 13.7% among the Swedish men studied.
The Bcl I cleavage reveals a polymorphism localized in the ®rst intron of the GR gene. 32 The functional signi®cance of such a polymorphism might be questionable unless it is interfering with the splicing of the primary mRNA, particularly when localized at the initiation of transcription as is the case with the polymorphism in question. Alternatively, the ®ndings might indicate functionally signi®cant polymorphisms in adjacent parts of the gene locus, such as the promotor area. A faulty function of the GR promotor would be expected to interfere with the regulation of GR density, and therefore with an inef®cient control of the feedback regulation of cortisol secretion. If this is the case, much of the observed abnormalities would be possible to explain. Therefore, the promotor region of the GR gene is now being sequenced.
Pathogenetic factors
The review above has indicated the fundamental impact of perceived stress in the pathogenetic chain of events. Stress is indeed the main activator of the HPA axis and may, when prolonged and intense, disrupt the entire regulatory system with even loss of brain substance in regulatory areas. 12, 33 Other studies have also indicated the involvement of stress by utilizing standardized laboratory stress methods. 3, 20 Stress factors may be de®ned as mental or physical stressors. Among the former are conditions in the psycho-social and socio-economic environment, which create a basis for a stress reaction of the defeat, depressive or helplessness character, which is typically followed by HPA axis activation. 34 Physical stressors are provided by pain, cold, starvation, physical exertion and toxins, including alcohol in excess and tobacco smoking. Infections may also be included in this category. Some authorities include psychiatric disease, or traits of disease such as depression and anxiety among stressors. 12 Since this is a rather diffuse area and highly dependent on coping ability and personality characteristics, stress is sometimes pragmatically de®ned as responses of the autonomic and endocrine systems to various environmental factors.
In our studies we have identi®ed several of the factors mentioned above as known stressors. These include psycho-social and socio-economic handicaps, alcohol and smoking and psychiatric symptoms. Furthermore, previous studies also indicate the inuence of minor infections such as otitis and bronchitis. 35 ± 38 
Concluding remarks
The results of the studies referred to above have clearly opened up possibilities of understanding a probably major factor in generation of prevalent human diseases. We believe, based on the evidence provided, that the following chain of events is occurring. Environmental stress is activating both the centres for the HPA axis and central sympathetic nervous system in an arousal reaction which leads to peripheral endocrine ± metabolic and haemodynamic consequences. When prolonged, this is leading to diabetes, type 2, cardiovascular disease and stroke. The dramatic power of the activity and functional status of the HPA axis is clearly demonstrated by the recently reported results.
The sensitivity to environmental stressors is individually different and the coping ability to stressors is highly variable. When the`coping ®lter' is not suf®-cient, signals reach the hypothalamic centres where, for the HPA axis, the regulatory feedback mechanism seems to be de®cient in susceptible individuals, which then might develop a poor regulation of the HPA axis and disease. This may well be based on molecular genetic defects, and one possibility might be a polymorphism of the GR gene or its promotor.
The prevalent diseases of the cardiovascular system, diabetes, type 2 and stroke are the endpoints of different pathogenetic pathways. Powerful risk factors are insulin resistance, dyslipidaemia, hypertension and thromboembolic mechanisms. Clearly speci®c abnormalities may lead to the expression of these risk factors. It seems, however, equally clear that central arousal might be a common origin for the appearance of the mentioned risk factors. The prevalence of perturbations along this mechanism cannot be stated with certainty. However, the prevalence has been estimated of two major components of the result of HPA axis activation, visceral distribution of body fat and insulin resistance. Both are in the order of 20 ± 25% of the middle-aged population. 15, 36, 37 It therefore seems likely that the HPA axis pathway described here is a major cause of prevalent disease.
